story of the week
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial
J. Clin. Oncol 2019 Sep 16;[EPub Ahead of Print], HA Kim, JW Lee, SJ Nam, BW Park, SA Im, ES Lee, YS Jung, JH Yoon, SS Kang, SJ Lee, KH Park, J Jeong, SH Cho, SY Kim, LS Kim, BI Moon, MH Lee, TH Kim, C Park, SH Jung, G Gwak, J Kim, SH Kang, YW Jin, HJ Kim, SH Han, W Han, MH Hur, WC NohFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.